First-into-human Study of NS-136 in Healthy Subjects

NCT06345703 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Placebo
DRUG: NS-136 tablet

Sponsor

NeuShen Therapeutics